Steve Arlington

Steve Arlington is an experienced business advisor and leader in the life sciences sector, currently serving as a Business Advisor at electronRx since March 2025 and as a Board Advisor at Phesi since January 2018. Arlington's extensive background includes roles such as Non-Executive Director at CIS ONCOLOGY LIMITED and Edge Health UK, as well as Non-Executive Chairman at Rivela and ENGITIX. Previously, Arlington held the position of President at the Pistoia Alliance, where efforts focused on enhancing innovation in life sciences R&D. Educational credentials include a BSc and PhD in Biological Sciences with a specialization in Immunology from the University of Birmingham.